CRSP
CRISPR Therapeutics AG
Stock
$55.43−0.01 (−0.02%)Close Oct 2, 2026
- Research and development, 2025
- $285M
- YoY, 2025
- −8.2%
- 5-year CAGR
- +5.2%
- 10-year CAGR
- +36.6%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $285M | −8.2% |
| 2024 | $310M | −19.9% |
| 2023 | $387M | −16.1% |
| 2022 | $462M | +35.6% |
| 2021 | $341M | +53.8% |
| 2020 | $221M | +23.4% |
| 2019 | $179M | +57.6% |
| 2018 | $114M | +63.0% |
| 2017 | $70M | +65.3% |
| 2016 | $42M | +235.9% |
| 2015 | $13M | +731.0% |
| 2014 | $1.5M | — |